Divergence of variant antibodies following SARS-CoV-2 booster vaccines in myeloma and impact of hybrid immunity

Hematological malignancies are associated with an increased risk of complications during SARS-CoV-2 infections. Primary series or monovalent booster vaccines reduce disease severity, hospitalization, and death among multiple myeloma patients. We characterized virus-neutralizing and spike-binding antibody profiles following monovalent (WA1) or bivalent (WA1/BA.5) SARS-CoV-2 booster vaccination in MM patients. Bivalent vaccination improved the breadth of binding antibodies but not neutralization activity against contemporary variants. Hybrid immunity and immune imprinting impact vaccine-elicited immunity.

Authors

Institutions

Publication Details

Journal
npj Vaccines
Published
2024-10-27
DOI
https://doi.org/10.1038/s41541-024-00999-6
Citations
2
Primary Topic
SARS-CoV-2 and COVID-19 Research
Type
article
Field-Weighted Citation Impact
0.78

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Divergence of variant antibodies following SARS-CoV-2 booster vaccines in myeloma and impact of hybrid immunity

Kelly E. Manning, Bushra Wali, Nisha S. Joseph, Craig C. Hofmeister et al.
2 citations
npj Vaccines
SARS-CoV-2 and COVID-19 Research
0.78
article

Divergence of variant antibodies following SARS-CoV-2 booster vaccines in myeloma and impact of hybrid immunity

Kelly E. Manning, Bushra Wali, Nisha S. Joseph, Craig C. Hofmeister, Ajay K. Nooka, Sagar Lonial, Mehul S. Suthar, Jeffrey M. Switchenko, Madison Ellis, Renee Julia Manalo, Kavita M. Dhodapkar, Maryam I. Azeem, Jonathan L. Kaufman, Madhav V. Dhodapkar, Alberto Moreno
article en
2 citations

Abstract

Hematological malignancies are associated with an increased risk of complications during SARS-CoV-2 infections. Primary series or monovalent booster vaccines reduce disease severity, hospitalization, and death among multiple myeloma patients. We characterized virus-neutralizing and spike-binding antibody profiles following monovalent (WA1) or bivalent (WA1/BA.5) SARS-CoV-2 booster vaccination in MM patients. Bivalent vaccination improved the breadth of binding antibodies but not neutralization activity against contemporary variants. Hybrid immunity and immune imprinting impact vaccine-elicited immunity.

npj VaccinesVol. 9(1)
Emory Healthcare (US), Emory University (US), Piedmont Cancer Institute (US), Aflac (United States) (US), Children's Healthcare of Atlanta (US), Winship Cancer Institute, Emory National Primate Research Center
Emory University, Children's Healthcare of Atlanta, National Institutes of Health, Winship Cancer Institute, National Cancer Institute, National Institute of Allergy and Infectious Diseases
Zero hunger
Openalex Percentile: Top 27%
SARS-CoV-2 and COVID-19 Research
0.78
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.